Shane Kovacs's most recent trade in Olema Pharmaceuticals Inc was a trade of 320,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 320,000 | 320,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 68,250 | 578,708 | - | 0 | Common Stock | |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Sale of securities on an exchange or to another person at price $ 8.66 per share. | 09 Dec 2024 | 17,950 | 543,955 | - | 8.7 | 155,447 | Common Stock |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Sale of securities on an exchange or to another person at price $ 9.37 per share. | 09 Dec 2024 | 16,803 | 561,905 | - | 9.4 | 157,444 | Common Stock |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Sale of securities on an exchange or to another person at price $ 9.39 per share. | 09 Dec 2024 | 406 | 543,549 | - | 9.4 | 3,812 | Common Stock |
| Olema Pharmaceuticals Inc | Shane Kovacs | Ch. Operating & Financial Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.02 per share. | 15 Nov 2024 | 25,000 | 510,458 | - | 7.0 | 175,500 | Common Stock |
| Olema Pharmaceuticals Inc | Shane Kovacs | Ch. Operating & Financial Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 25,000 | 162,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 304,500 | 304,500 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kovacs Shane | CH. OPERATING & FINANCIAL OFF. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jan 2024 | 50,000 | 187,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.02 per share. | 12 Jan 2024 | 50,000 | 484,987 | - | 7.0 | 351,000 | Common Stock |
| Olema Pharmaceuticals Inc | Kovacs Shane | CH. OPERATING & FINANCIAL OFF. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 10,000 | 237,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.02 per share. | 12 Dec 2023 | 10,000 | 434,987 | - | 7.0 | 70,200 | Common Stock |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2023 | 36,750 | 443,729 | - | 0 | Common Stock | |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Sale of securities on an exchange or to another person at price $ 13.89 per share. | 20 Nov 2023 | 9,145 | 424,987 | - | 13.9 | 127,024 | Common Stock |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Sale of securities on an exchange or to another person at price $ 14.83 per share. | 20 Nov 2023 | 8,897 | 434,832 | - | 14.8 | 131,943 | Common Stock |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Sale of securities on an exchange or to another person at price $ 15.27 per share. | 20 Nov 2023 | 700 | 434,132 | - | 15.3 | 10,689 | Common Stock |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Apr 2023 | 10,000 | 396,197 | - | - | Common Stock | |
| Olema Pharmaceuticals Inc | Shane Kovacs | Ch. Operating & Financial Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 02 Sep 2022 | 20,000 | 381,197 | - | - | Common Stock | |
| Olema Pharmaceuticals Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 247,000 | 247,000 | - | - | Stock Option (Right to Buy) |